The efficacy of combination of chemotherapy and immunotherapy compared with immunotherapy alone for NSCLC

被引：0
|
作者：
Hirano, Satoshi [1 ]
Takahashi, Hidekazu [1 ]
Hiroyuki, Amano [2 ]
Toshiaki, Inazaki [2 ]
Kuroki, Tsuguko [2 ]
Urano, Akira [2 ]
Kure, Fujihiro [2 ]
Fujita, Tetsuo [2 ]
Nakamura, Makoto [2 ]
Nakamura, Sukeyuki [2 ]
机构：
[1] Funabashi Municipal Med Ctr, Dept Med Oncol, Funabashi, Chiba, Japan
[2] Funabashi Municipal Med Ctr, Dept Resp Med, Funabashi, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P61-2
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [31] Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited
    Gabrilovich, Dmitry I.
    LANCET ONCOLOGY, 2007, 8 (01): : 2 - 3
  • [32] Modeling of Combination Chemotherapy and Immunotherapy for Lung Cancer
    Curtis, Louis T.
    Frieboes, Hermann B.
    2019 41ST ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2019, : 273 - 276
  • [33] COMBINATION CHEMOTHERAPY AND IMMUNOTHERAPY OF TRANSPLANTABLE MURINE LEUKEMIA
    KOLLMORGEN, GM
    ERWIN, DN
    KILLION, JJ
    HOGE, AF
    SANSING, WA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 69 - +
  • [34] COMBINATION OF IMMUNOTHERAPY AND CHEMOTHERAPY TO EXPERIMENTAL TUMORS IN RATS
    HOSOKAWA, M
    SENDO, F
    GOTOHDA, E
    KOBAYASHI, H
    GANN, 1971, 62 (01): : 57 - +
  • [35] How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
    Nardone, Valerio
    Pastina, Pierpaolo
    Giannicola, Rocco
    Agostino, Rita
    Croci, Stefania
    Tini, Paolo
    Pirtoli, Luigi
    Giordano, Antonio
    Tagliaferri, Pierosandro
    Correale, Pierpaolo
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [36] Music therapy, quality of life and efficacy of immunotherapy for NSCLC
    Duan, Xu
    Jia, Yingxue
    Chai, Jiaying
    Li, Wen
    Tang, Lingxue
    Li, Anlong
    Ge, Han
    Huang, Runze
    Cheng, Huaidong
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023,
  • [37] Efficacy of immunotherapy in Chinese patients with KRASmutant advanced NSCLC
    Wang, Z.
    Han, X.
    Peng, L.
    Guo, J.
    Kong, L.
    Huang, Y.
    Tang, N.
    Zhang, J.
    Wang, M.
    He, X.
    Li, Z.
    Peng, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1067 - S1067
  • [38] The hematologic toxicities of chemo-immunotherapy compared to chemotherapy alone: A systematic review and meta-analysis
    Eiger, D.
    Agostinetto, E.
    Caparica, R.
    Franzoi, M. A.
    Brandao, M.
    Buisseret, L.
    de Caluwe, A.
    Gimenes, D.
    Simon, S. D.
    Ponde, N. F.
    de Azambuja, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S1433 - S1434
  • [39] Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
    Tianqian Zhang
    Dorothee Herlyn
    Cancer Immunology, Immunotherapy, 2009, 58 : 475 - 492
  • [40] Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
    Zhang, Tianqian
    Herlyn, Dorothee
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (04) : 475 - 492
12345